Summary of Studies on Shenling Baizhu (Stomach Fortifier™) Capsule

Chinese Use: Chronic loose bowels, chronic colonitis, chronic hepatitis, chronic nephritis, chronic nascsinusitis, pulmonary heart disease in catabasis, radiation disease.

Modern studies on pharmacodynamics show that this product yields actions of regulating the movements of gastro-intestinal tract and improvement of metabolism.

1. Regulation of the movements of gastro-intestinal tract: small dosage of this product in decoction form reveals excitation on intestine, eliminates the partial inhibition of adrenalin on the intestine, while large dose inhibits the contraction of intestine, and antagonizes the intestinal contraction induced by pilocarpine and barium chloride, strengthens the absorption of water and chloride ion in the intestine.

2. Improvement of metabolism: Application of this product for treatment of intestinal disorders of deficient splenic-qi type (chronic gastritis, chronic enteritis, gastric and duodenal ulcers) reveals that, before the treatment, the creatinine, uric acid and urea nitrogen were all lower than normal. It increases markedly after the treatment and also increases the immunity and hemorrheological indices.

Clinically, this product is applied for the treatment of chronic diarrhea, chronic enteritis, chronic hepatitis, chronic nephritis, chronic sinusitis, relieved stage of cor pulmonale, and radial disorders.

1. Chronic diarrhea: 56 cases were treated, with 29 cases cured: 15 cases, markedly effective; 7 cases, ameliorated; 5 cases, ineffective. For infantile diarrhea, 23 cases were treated with modified product, with all cases cured. The time of healing was 5 days at the shortest and 22 days at the longest. 81 cases of asthenic splenic diarrhea were treated with this modified product, one dose daily, 500ml for each dose with date solution together, supplemented with water supplemented according to the condition of dehydration, 81 cases were all cured within 3~5 days.

2. Chronic enteritis: 60 cases of allergic enteritis of splenic asthenia-damp type were treated with this product with additives, 1 dose each day in two portions in the morning and evening separately for 6~18 days. 38 cases were cured; 14 cases, markedly effective; 6 cases, ameliorated; 2 cases, ineffective; the total effective rate being 97%. 30 cases of ulcerative colitis were treated with oral product combined with enema (a concentrated solution made of Radix Scrophulariae, Radix Astragali seu Hedysari, Rhizoma Bletillae, and Cortex Phellodendri 150ml, plus Yunnan white medicine 2g), once every evening with 10 sessions constituting a therapeutic course. After 3 courses of treatment, 13 cases were basically cured; 16 cases, ameliorated; 1 case, ineffective.

3. Chronic hepatitis, hepatic cirrhosis: 148 cases were treated with this modified product, supplemented with diphenyl bi-fat, 100 cases (67.7%) were markedly effective; 40 cases (27.0%), effective; 8 cases, ineffective; the total effective rate being 94.6%. In the 140 cases of markedly effective and effective results, 76 cases were followed up for 6 months without relapse. Among them, 105 cases with positive HBsAg, 24 of them turned negative, 8 cases turned negative with only one exam; 10 cases, with 2 exams; 6 cases, 3 exams. For liver cirrhosis, after treatment, comprehensive evaluation of exam revealed that, in 30 cases, all symptoms, β-ultrasonic exam, hepatic function exam were cured in 9 cases; 14 cases, ameliorated; 3 cases, ineffective; 4 cases, aggravated.

4. Chronic nephritis: 129 cases of splenic asthenic and damp stagnation type were treated, with 22 cases totally remitted; 35 cases, basically remitted; 39 cases, ameliorated; 13 cases, ineffective; 15 cases of hidden type chronic nephritis were treated with this modified product with 3 cases of pure albuminuria basically remitted; 4 cases with scanty albumen, RBC and cast were basically remitted; 2 cases partially remitted.

5. Chronic nasal sinusitis: this product plus Radix Astragali seu Hedysari, Fructus Xanthii, Radix Angelica dahurica, Herba Houttuyaniae were used as basic recipe for 68 cases of infantile patients, 1 dose daily, for 10 days as a course. Results: 18 cases (26.5%) were cured; 25 cases (36.8%), markedly effective: 20 cases (29.4%), effective; 5 cases (7.5%), ineffective, the total effective rate being 92.7%.

6. Cor pulmonale: 78 cases of remittent stage of cor pulmonale were treated with this product. Results: 34 cases markedly effective; 11, ameliorated; 13, ineffective (4 cases died), the total effective rate being 83.3%, fatal rate, 5.1%.

7. Lung tumor and radial disorder: 50 cases of esophageal cancer, pyloric cancer and gastro-intestinal disturbance were treated with this product plus acu-moxibustion. Results: 43 cases were markedly effective; 5 cases, effective; 2 cases, ineffective, the total effective rate being 96%. Cases of malignant tumor after chemo- or radio-therapy may appear tasteless, vertigo, nausea, vomiting, epigastric distress, averse to fat, anorexia, white greasy fur. After treated with this modified product in 96 cases, 23 cases (34.4%) were markedly effective; 46 cases (47.9%), effective; 17 cases (17.7%) were ineffective, the total effective rate being 82.3%.

Excerpt from A Guide to TCM Products, China Academy of Traditional Chinese Medicine, 2003

This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any diseases.